摘要 |
The present invention reports stimulatory effects of interleukin 8 (IL-8) on human osteoclast formation and bone resorption, indicating IL-8 as a potent activator of bone destruction common in metastatic bone diseases. Tumor growth and osteolysis were inhibited by anti-IL-8 antibody or antisense IL-8. Additionally, IL-8 was able to confer an osteolytic phenotype on non-osteolytic cancer cells. These results identify tumor-induced osteolysis and bone resorption as potential targets of anti-IL-8 therapy.
|